Level C· Early human research exploring benefitsProspective StudyPubMed

Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells.

Sun N., Panetta NJ., Gupta DM., Wilson KD., Lee A., Jia F.

Prospective Study on Face & Skin, published in Proc Natl Acad Sci U S A (2009) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Proc Natl Acad Sci U S A (2009)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
19805220
PMCID
PMC2739869
DOI
10.1073/pnas.0908450106
Citations
352

Abstract (original English)

Ectopic expression of transcription factors can reprogram somatic cells to a pluripotent state. However, most of the studies used skin fibroblasts as the starting population for reprogramming, which usually take weeks for expansion from a single biopsy. We show here that induced pluripotent stem (iPS) cells can be generated from adult human adipose stem cells (hASCs) freshly isolated from patients. Furthermore, iPS cells can be readily derived from adult hASCs in a feeder-free condition, thereby eliminating potential variability caused by using feeder cells. hASCs can be safely and readily isolated from adult humans in large quantities without extended time for expansion, are easy to maintain in culture, and therefore represent an ideal autologous source of cells for generating individual-specific iPS cells.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
AdipocytesAdultAdult Stem CellsAgedAlkaline PhosphataseAntigens, CDAntigens, SurfaceCell Culture TechniquesCell DedifferentiationCell Line

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research